Defining Reversal of Alopecia Areata (AA) Phenotype With Dupilumab in Patients With and Without Associated Atopic Dermatitis (AD)
Latest Information Update: 28 Oct 2022
Price :
$35 *
At a glance
- Drugs Dupilumab (Primary)
- Indications Alopecia areata
- Focus Therapeutic Use
- 22 Oct 2022 Results of scalp biomarker analysis published in the Allergy
- 30 Aug 2021 Results published in the Allergy
- 05 Jan 2021 Status changed from active, no longer recruiting to completed.